Porton Advanced Announces Collaboration with Eureka Therapeutics to Accelerate T‑Cell Therapy Development
Porton Advanced Congratulates Esteemed Partner Lion TCR on IND Approval from NMPA for mRNA TCR-T Cell Therapy GZL-016 in Hepatitis B-Related Liver Cancer
Porton Advanced and Geneseed Biotech Enter into Strategic Collaboration to Focus on Advancing circRNA Innovative Therapeutics
Porton Advanced introduces the MaxCyte ExPERT GTx Flow Electroporation instrument, continuing to provide customers with end-to-end cell and gene therapy CRO & CDMO services
Porton Advanced and BRL Medicine Build Strategic Partnership to Accelerate Commercialization of Gene and Cell Therapies
Porton Advanced and Bennu Biotherapeutics Announced a Strategic Partnership to Accelerate cell engineering Development for Solid Tumors
